GlycoMimetics, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.62
+1.35 (10.17%)
At close: Jun 18, 2025, 4:00 PM
14.55
-0.07 (-0.48%)
After-hours: Jun 18, 2025, 4:37 PM EDT

GlycoMimetics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-29.49-37.88-36.9-46.69-63.43-51.03
Upgrade
Depreciation & Amortization
0.020.040.150.210.260.27
Upgrade
Loss (Gain) From Sale of Assets
0.050.050.0100-
Upgrade
Asset Writedown & Restructuring Costs
0.370.37----
Upgrade
Stock-Based Compensation
3.954.773.563.866.096.9
Upgrade
Other Operating Activities
0.230.40.860.830.750.68
Upgrade
Change in Accounts Payable
-0.65-0.54-0.1-1.140.020.65
Upgrade
Change in Other Net Operating Assets
-0.171.7-2.46-3.52-1.183.28
Upgrade
Operating Cash Flow
-25.7-31.1-34.88-46.46-57.49-39.24
Upgrade
Capital Expenditures
-0-0.01-0.02-0.08-0.01-0.07
Upgrade
Sale of Property, Plant & Equipment
0.030.03----
Upgrade
Investing Cash Flow
0.030.02-0.02-0.08-0.01-0.07
Upgrade
Issuance of Common Stock
00.0128.824.1610.7218.14
Upgrade
Financing Cash Flow
00.0128.824.1610.7218.14
Upgrade
Net Cash Flow
-25.67-31.07-6.08-42.38-46.78-21.17
Upgrade
Free Cash Flow
-25.7-31.11-34.9-46.54-57.5-39.31
Upgrade
Free Cash Flow Margin
---349012.97%-62055.57%-4958.28%-386.80%
Upgrade
Free Cash Flow Per Share
-39.85-48.25-55.10-88.60-111.76-85.98
Upgrade
Levered Free Cash Flow
-11.34-14.28-21.88-30.82-33.32-20.62
Upgrade
Unlevered Free Cash Flow
-11.34-14.28-21.88-30.82-33.32-20.62
Upgrade
Change in Net Working Capital
0.44-1.241.025.170-4.47
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.